Kellogg's cereal business begins trading as standalone company W.K. Kellogg

  • 📰 NBCLA
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 59%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

As part of the separation, Kellogg has been renamed Kellanova but is still trading under the ticker “K.”

W.K. Kellogg, a spinoff of Kellogg's cereal business, began trading on the New York Stock Exchange.

As part of the separation, Kellogg has been renamed Kellanova but is still trading under the ticker"K." Shareholders received one share of W.K. Kellogg for every four shares of Kellogg they owned as of Sept. 21. Kellogg's cereal business began trading on the New York Stock Exchange at $13.80 per share as W.K. Kellogg after spinning off from its parent company on Monday morning.. It now houses snacking brands like Pringles and Cheez-It and its North American frozen-food unit, which includes Morningstar Farms.Get Southern California news, weather forecasts and entertainment stories to your inbox.Shares of Kellanova were down roughly 3% in morning trading, and W.K. Kellogg's stock fell 5%.

Shareholders received one share of W.K. Kellogg for every four shares of Kellogg they owned as of Sept. 21.the planned separation in June 2022. Cereal sales have stagnated as consumers choose from a wider variety of options for breakfast and prioritize convenience.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 319. in MY

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boomKellogg, J.M. Smucker and other food companies are making big bets on snacking, but the rise of Wegovy and Ozempic could pose a threat to future sales growth.
Source: NBCLA - 🏆 319. / 59 Read more »